Logo-npj
ePublished: 17 May 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2015;4(2): 61-62.
  Abstract View: 8649
  PDF Download: 4044

Commentary

Focal segmental glomerulosclerosis and end-stage kidney disease in children

Alaleh Gheissari*

1 Department of Pediatric Nephrology, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding Author: *Corresponding author: Prof. Alaleh Gheissari, , Email: gheisari@med.mui.ac.ir

Implication for health policy/practice/research/medical education:

Focal segmental glomerulosclerosis (FSGS) is one of the principal causes of end-stage kidney disease in children worldwide. During the past decades, different genes mutations have been implicated in pathogenesis of resistant sporadic and hereditary familial forms of FSGS. Nephrin, podocin, alpha-actinin 4 (ACTN4) are some of podocyte structural proteins that their role in pathogenesis of FSGS have already been discussed. However, the role of TRPC6, a transient receptor potential ion channel, in hereditary forms of FSGS has been discovered. Regarding the roles of TRPC6 channels in proteinuria new trends to use TRPC6 blocking agents though challenging are developed.

Please cite this paper as: Gheissari A. Focal segmental glomerulosclerosis and end-stage kidney disease in children. J Nephropharmacol. 2015;4(2):61-62.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 8650

Your browser does not support the canvas element.


PDF Download: 4044

Your browser does not support the canvas element.